Jinqi Xue

1.3k total citations · 1 hit paper
30 papers, 796 citations indexed

About

Jinqi Xue is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jinqi Xue has authored 30 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Jinqi Xue's work include Cancer Cells and Metastasis (5 papers), Breast Cancer Treatment Studies (5 papers) and MicroRNA in disease regulation (3 papers). Jinqi Xue is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Breast Cancer Treatment Studies (5 papers) and MicroRNA in disease regulation (3 papers). Jinqi Xue collaborates with scholars based in China. Jinqi Xue's co-authors include Zhiguang Chen, Xi Gu, Qin Fu, Tao Shen, Jiawen Bu, Shuai Mu, Yueting Hu, Yang Liu, Peng Qiu and Zhenyong Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Annals of the New York Academy of Sciences.

In The Last Decade

Jinqi Xue

29 papers receiving 790 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in immunotherapy for triple-negative breast cancer

2023 178 citations Jinqi Xue, Jiawen Bu et al. Molecular Cancer profile →

Peers

Jinqi Xue

ONCOL

IMMUN

PRM

Liang Han China

Yang Xie United States

Geeta Rao United States

Zhongqiu Zhou China

Klaudia Skrzypek Poland

Xuemei Sun China

Jay Sharma United States

Pengzhan Zhao China

Jingbo Sun China

Liang Han China

Jinqi Xue

394 ×0.9

388 ×1.7

ONCOL

192 ×1.0

119 ×1.0

IMMUN

72 ×0.8

PRM

Citations per year, relative to Jinqi Xue Jinqi Xue (= 1×) peers Liang Han

Countries citing papers authored by Jinqi Xue

Since Specialization

Citations

This map shows the geographic impact of Jinqi Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinqi Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinqi Xue more than expected).

Fields of papers citing papers by Jinqi Xue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinqi Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinqi Xue. The network helps show where Jinqi Xue may publish in the future.

Co-authorship network of co-authors of Jinqi Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Jinqi Xue. A scholar is included among the top collaborators of Jinqi Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinqi Xue. Jinqi Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Qi, et al.. (2024). FOXQ1, deubiquitinated by USP10, alleviates sepsis-induced acute kidney injury by targeting the CREB5/NF-κB signaling axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(7). 167331–167331. 6 indexed citations

Gao, Hongli, Zhuo Xi, Jinqi Xue, et al.. (2024). Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options. Molecular Cancer. 23(1). 88–88. 31 indexed citations

Chen, Zhiguang, et al.. (2024). MAGP2 promotes osteogenic differentiation during fracture healing through its crosstalk with the β‐catenin pathway. Journal of Cellular Physiology. 239(4). e31183–e31183.

Bu, Jiawen, Yixiao Zhang, Sijin Wu, et al.. (2023). KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer. Nature Communications. 14(1). 2602–2602. 36 indexed citations

Yang, Liu, Jinqi Xue, Shiqing Liu, et al.. (2023). Neuroinflammation: The central enabler of postoperative cognitive dysfunction. Biomedicine & Pharmacotherapy. 167. 115582–115582. 62 indexed citations

Gao, Hongli, Ce Ji, Xiaopeng Yu, et al.. (2023). Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application. Journal of Experimental & Clinical Cancer Research. 42(1). 225–225. 59 indexed citations

Chen, Guanglei, Lisha Sun, Xi Gu, et al.. (2023). FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway. Science China Life Sciences. 66(12). 2805–2817. 11 indexed citations

Chen, Zhiguang, et al.. (2023). Microfibril-Associated Glycoprotein-2 Promoted Fracture Healing via Integrin αvβ3/PTK2/AKT Signaling. Laboratory Investigation. 103(7). 100121–100121. 3 indexed citations

Xing, Fei, Hongli Gao, Guanglei Chen, et al.. (2023). CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer. Molecular Cancer. 22(1). 6–6. 31 indexed citations

10.

Xue, Jinqi, Guanglei Chen, Fei Xing, et al.. (2023). Neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple-positive breast cancer: A pilot trial.. Journal of Clinical Oncology. 41(16_suppl). e12603–e12603. 1 indexed citations

11.

Qiao, Xinbo, Yixiao Zhang, Zhan Zhang, et al.. (2023). KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes. Asian Journal of Pharmaceutical Sciences. 18(3). 100814–100814. 7 indexed citations

12.

Shen, Yanyan, Jinqi Xue, Yi Jiang, et al.. (2022). Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer. World Journal of Surgical Oncology. 20(1). 398–398. 1 indexed citations

13.

Xue, Jinqi, Xudong Zhu, Xinbo Qiao, et al.. (2022). CEMIP as a potential biomarker and therapeutic target for breast cancer patients. International Journal of Medical Sciences. 19(3). 434–445. 13 indexed citations

14.

Qiao, Xinbo, Yixiao Zhang, Lisha Sun, et al.. (2021). Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis. eLife. 10. 24 indexed citations

15.

Zhang, Yixiao, Xudong Zhu, Xinbo Qiao, et al.. (2020). LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer. Journal of Cellular and Molecular Medicine. 24(16). 9125–9134. 19 indexed citations

16.

Zhu, Xudong, Yang Bai, Xi Gu, et al.. (2020). HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients. International Journal of Medical Sciences. 17(17). 2773–2789. 13 indexed citations

17.

Zhu, Xudong, Jinqi Xue, Xi Gu, et al.. (2019). Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast Cancer. Journal of Cancer. 10(23). 5661–5670. 5 indexed citations

18.

Chen, Guanglei, Yixiao Zhang, Jinqi Xue, et al.. (2019). Surgical Outcomes of Implant-based Breast Reconstruction Using TiLoop Bra Mesh Combined With Pectoralis Major Disconnection. Annals of Plastic Surgery. 83(4). 396–400. 13 indexed citations

19.

Chen, Zhiguang, Jinqi Xue, Tao Shen, Shuai Mu, & Qin Fu. (2015). Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway. International Journal of Molecular Medicine. 37(2). 329–338. 105 indexed citations

20.

Li, Jianyi, Jia Shi, Wenhai Zhang, et al.. (2013). A New Technique That Complements Sentinel Lymph Node Biopsy: Lymph Node Dissection Under the Intercostobrachial Nerves in Early-Stage Breast Cancer. Clinical Breast Cancer. 13(3). 212–218. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact